Home » Topics » Regulatory

Regulatory
RSS

Launch of delayed-release oral suspension formulation of Prevacid

Feb. 13, 2002

Xenical approved in Canada for use in type 2 diabetics

Feb. 13, 2002

Tracleer fails to meet primary endpoints in phase III CHF study

Feb. 12, 2002

BMS and Sanofi-Synthelabo withdraw irbesartan sNDA

Feb. 8, 2002

Xopenex approved for pediatric use in bronchospasm

Feb. 7, 2002

Once-daily one-tablet formulation of Sustiva approved

Feb. 6, 2002

First approval obtained for antihypertensive combination developed in Spain

Feb. 5, 2002

Gleevec approved for gastrointestinal stromal tumors

Feb. 5, 2002

Zometa receives positive opinion for treatment of cancer-related bone metastases

Feb. 4, 2002

Amgen's Neulasta approved for febrile neutropenia

Feb. 4, 2002

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 29, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for April 28, 2026
Chinese biotechs gain leverage as partners in dealmaking
BioWorld
China’s biotech ecosystem has crossed an inflection point, and Chinese biotechs are gaining leverage in dealmaking, executives from multinational companies said...
Plasticity, properly parsed, provides psychiatric platform
BioWorld
If Benjamin Braddock, of The Graduate fame, were a young neuroscientist in the 21st century instead of a liberal arts graduate in 1967, the advice he received...
Roche identifies new TREM2 agonists
BioWorld Science
F. Hoffmann-La Roche Ltd. and Hoffmann-La Roche Inc. have prepared and tested new compounds acting as triggering receptor expressed on myeloid cells 2 (TREM2)...